EVOGENE Stock Profile

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:3em;padding-top: 40px;;'>EVG</div>


1 / 100

Odds of Distress

Analyze Filter   Check how we calculate scores
Equity ratings for EVOGENE LTD are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting November 27, 2019 and ending today February 25, 2020. Click here to learn more.


Evogene Ltd., a biotechnology company, engages in developing various products for life science markets through the use of computational predictive biology platform in the United States, Israel, Germany, and internationally. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel. EVOGENE LTD operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 150 people. more on EVOGENE LTD
CEOOfer HavivView All
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Few selected profitability drivers of EVOGENE LTD representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Net Income
Operating Income
Net Income Per Employee
Operating Margin
Gross Margin
Profit Margin
EVOGENE LTD (EVGN) is traded on Tel Aviv Stock Exchange in Israel and employs 150 people. The company currently falls under 'Small-Cap' category with current market capitalization of 127.79 M. EVOGENE LTD operates under Healthcare sector and is part of Biotechnology industry. The entity has 25.75 M outstanding shares. EVOGENE has accumulated about 52.12 M in cash with (15.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.02.
Check EVOGENE LTD Probability Of Bankruptcy

EVOGENE Stock Price Odds Analysis

Odds Below 487.0HorizonTargetOdds Above 487.0
15.77%30 days 487.00 84.13%
Based on normal probability distribution, the odds of EVOGENE LTD to move above current price in 30 days from now is about 84.13 (This EVOGENE LTD probability density function shows the probability of EVOGENE LTD Stock to fall within a particular range of prices over 30 days) .

EVOGENE LTD Income Statement Over Time

Direct Expenses    Net Income    Revenues    

EVOGENE Stock Against Markets

Did you try this?

Run Financial Widgets Now


Financial Widgets

Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
All  Next Launch Module

EVOGENE LTD Corporate Directors

Oded Shoseyov Director
Adina Makover Independent Director
Adrian Percy Director
Continue to Investing Opportunities. Please also try Piotroski F Score module to get piotroski f score based on binary analysis strategy of nine different fundamentals.
Company logos by clearbit